National Cancer Institute
Found 573 results for your search:
Total relevant funding to Non Hodgkins Lymphoma for this search:
$119,514,716
Fiscal Year FY 2017
Cancer Type [Non Hodgkins Lymphoma]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 573 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
(PQ#9) Promoting Axon Stability to Prevent Therapy-induced Peripheral Neuropathy 1R01CA219866-01 $445,407 $445,407 DIANTONIO, AARON WASHINGTON UNIVERSITY
2
(PQ9)A redox-mediated mechanism of chemotherapy-induced cognitive impairment 1R01CA217934-01 $455,149 $455,149 ST CLAIR, DARET UNIVERSITY OF KENTUCKY
3
(PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies 5R01CA185372-04 $321,625 $321,625 RICHARDS, KRISTY CORNELL UNIVERSITY
4
0021.0001 CG 425 METAVIVOR 261200800001E $319,219,481 $33,722 UNKNOWN, UNKNOWN LEIDOS BIOMEDICAL RESEARCH, INC.
5
A cohort study among workers exposed to benzene in China ZIA CP010120-02060 $169,821 $33,964 Rothman, Nat DCEG (NCI)
6
A Follow-up Study for Causes of Cancer in Black Women 2U01CA164974-07 $2,195,369 $219,537 ROSENBERG, LYNN BOSTON UNIVERSITY MEDICAL CAMPUS
7
A Follow-up Study for Causes of Cancer in Black Women 5UM1CA164974-06 $639,740 $63,974 ROSENBERG, LYNN BOSTON UNIVERSITY MEDICAL CAMPUS
8
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1 ZIA BC 011064 $45,438 $9,088 Mock, Beverly CCR (NCI)
9
A multi-center international hospital-based case-control study of lymphoma in Asi ZIA CP010136-10512 $1,498,131 $1,498,131 Lan, Qing DCEG (NCI)
10
A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose 5R01CA190696-04 $299,009 $299,009 SCHATZ, JONATHAN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
11
A novel NKG2D-specific BiTE cancer immunotherapy 5R01CA164178-05 $336,150 $168,075 SENTMAN, CHARLES DARTMOUTH COLLEGE
12
A Novel Positron Emission Tomography Strategy for Early Detection and Treatment Monitoring of Graft-versus-host Disease 5R01CA201719-02 $361,504 $180,752 GAMBHIR, SANJIV STANFORD UNIVERSITY
13
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL 5R01CA196266-02 $502,591 $502,591 PENICHET, MANUEL UNIVERSITY OF CALIFORNIA LOS ANGELES
14
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies 1R21CA205106-01A1 $234,992 $234,992 OGEMBO, JAVIER BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
15
A Phase I trial combining IV fenretinide and IV safingol to target overproduction 4R44CA183316-02 $648,029 $648,029 SIMPSON, WILLIAM CERRX, INC.
16
A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles 1F30CA221250-01 $49,044 $49,044 SCHNORENBERG, MATHEW UNIVERSITY OF CHICAGO
17
A Role for KSHV in the Pathogenesis of Malignancies ZIA SC 010356 $317,262 $31,726 Tosato, Giovanna CCR (NCI)
18
A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors 5R21CA198237-02 $88,993 $17,799 DANHAUER, SUZANNE WAKE FOREST UNIVERSITY HEALTH SCIENCES
19
Abramson Cancer Center Support Grant 3P30CA016520-41S1 $125,000 $3,750 DANG, CHI UNIVERSITY OF PENNSYLVANIA
20
Abramson Cancer Center Support Grant 3P30CA016520-41S2 $62,491 $1,875 VONDERHEIDE, ROBERT UNIVERSITY OF PENNSYLVANIA
21
Abramson Cancer Center Support Grant 5P30CA016520-41 $7,810,244 $234,307 VONDERHEIDE, ROBERT UNIVERSITY OF PENNSYLVANIA
22
Activation of Proto-Oncogenes by Chromosomal Translocation ZIA SC 010378 $380,330 $190,165 Aplan, Peter CCR (NCI)
23
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu 5U54CA190152-04 $875,813 $402,874 GOPAL, SATISH UNIV OF NORTH CAROLINA CHAPEL HILL
24
Agricultural Cohort Consortium ZIA CP010119-10537 $50,451 $7,568 Beane Freeman, Laura DCEG (NCI)
25
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture ZIA CP010119-10527 $1,244,533 $124,453 Hofmann, Jonathan DCEG (NCI)
26
AIDS Malignancy Consortium (AMC) 5UM1CA121947-11 $22,965,613 $5,741,403 MITSUYASU, RONALD UNIVERSITY OF CALIFORNIA LOS ANGELES
27
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-04S1 $2,088,480 $104,424 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
28
Alliance for Clinical Trials in Oncology Operations Center 5U10CA180821-04 $11,145,123 $557,256 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
29
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor ZIA BC 011415 $13,582 $4,482 Kochenderfer, James CCR (NCI)
30
Allotransplant for DOCK8 deficiency ZIA BC 011374 $145,114 $72,557 Hickstein, Dennis CCR (NCI)
31
Alternative End-Joining in DNA Repair and Chromosomal Translocations 5F30CA189740-04 $49,044 $49,044 KUMAR, VIPUL HARVARD MEDICAL SCHOOL
32
Ambient dioxin exposure and cancer risk in women (IWHS and AHS) ZIA CP010125-10712 $56,170 $11,234 Jones, Rena DCEG (NCI)
33
Analysis and Therapeutic Targeting Non-proteolytic Protein Ubiquitination in Diffuse Large B Cell Lymphoma 5K22CA197014-02 $194,616 $194,616 YANG, YIBIN RESEARCH INST OF FOX CHASE CAN CTR
34
Anatomic Pathology Residency Program ZIE BC 011384 $1,094,457 $87,557 Barr, Frederic CCR (NCI)
35
Animal Model and Genotyping Core Support Facility ZIC BC 011047 $814,201 $162,840 DuBois, Wendy CCR (NCI)
36
Annual International Primary CNS Lymphoma Collaborative Group Meeting 2R13CA124293-10 $5,000 $2,500 BATCHELOR, TRACY MASSACHUSETTS GENERAL HOSPITAL
37
Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma 5R44CA144104-05 $1,002,741 $1,002,741 KLINGHOFFER, RICHARD PRESAGE BIOSCIENCES, INC.
38
Assisted Network-based Analysis of Cancer Gene Expression Studies 1R03CA216017-01 $83,750 $27,638 MA, SHUANGGE YALE UNIVERSITY
39
ATBC Lymphoma Studies ZIA CP010195-10733 $23,111 $10,400 Berndt, Sonja DCEG (NCI)
40
ATBC Study ZIA CP010195-03031 $1,161,432 $92,915 N/A DCEG (NCI)
41
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research ZIG BC 010856 $14,497,944 $724,898 Custer, Mary CCR (NCI)
42
BCR Signaling in ABC DLBCL ZIA BC 011354 $97,342 $97,342 Wilson, Wyndham CCR (NCI)
43
BET protein antagonist-based targeted therapy of Mantle Cell Lymphoma 1R01CA210250-01A1 $390,134 $390,134 BHALLA, KAPIL UNIVERSITY OF TX MD ANDERSON CAN CTR
44
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins ZIA BC 010030 $755,842 $37,792 Ambudkar, Suresh CCR (NCI)
45
Biochemical Basis of T Cell Activation ZIA BC 010304 $1,345,687 $672,843 Samelson, Lawrence CCR (NCI)
46
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda 5U54CA190146-04 $688,290 $199,604 PHIPPS, WARREN FRED HUTCHINSON CANCER RESEARCH CENTER
47
Biology and Transplantation of the Hematopoietic Stem Cell 5P01CA065493-23 $1,914,865 $210,635 WAGNER, JOHN UNIVERSITY OF MINNESOTA
48
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis ZIA BC 011334 $474,811 $23,741 Kaplan, Rosandra CCR (NCI)
49
Biomarkers of benzene exposure ZIA CP010121-02035 $57,383 $19,510 Rothman, Nat DCEG (NCI)
50
Bone Marrow Grafting for Leukemia and Lymphoma 5P01CA049605-28 $2,700,000 $1,512,000 NEGRIN, ROBERT STANFORD UNIVERSITY
Total relevant funding to Non Hodgkins Lymphoma for this search: $119,514,716
Showing 1 - 50 of 573 results
Go to top